Select a State

Global health R&D delivers for Massachusetts

US government investment in global health R&D has delivered

$731.1 million
to Massachusetts research institutions
8,400+ new jobs
for Massachusetts
4469

Neglected diseases in Massachusetts

Chikungunya cases
234
Dengue cases
33
HIV diagnoses
6241
Malaria cases
388
Tuberculosis cases
1916
West Nile cases
88
Zika cases
129

Massachusetts

--

Massachusetts's top USG-funded global health R&D institutions

Harvard University (including School of Public Health, Public Health AIDS Initiative, and Harvard Medical School)
$ 135 million
Massachusetts General Hospital (including CAMtech and Center for Integration of Medicine & Innovative Technology)
$ 93.4 million
Beth Israel Deaconess Medical Center
$ 89.8 million
Brigham and Women's Hospital
$ 82.3 million
University of Massachusetts Medical School
$ 80.4 million
Broad Institute
$ 44.1 million
Children's Hospital Boston (including Children's Hospital Corporation and Immune Disease Institute)
$ 51.8 million
Tufts University (including Tufts Medical Center)
$ 34.4 million
Dana-Farber Cancer Institute
$ 32 million
Boston University (including Boston University Medical Campus and Center for Global Health and Development)
$ 24.3 million

Massachusetts industry in global health R&D

AbbVie
Location(s):
Worcester
Affinivax
Location(s):
Cambridge
Alere
Location(s):
Waltham
Amgen
Location(s):
Cambridge, Woburn
Astellas
Location(s):
Cambridge, Marlborough
AstraZeneca
Location(s):
Waltham
Beckman Coulter
Location(s):
Danvers
Bristol-Myers Squibb
Location(s):
Cambridge, Devens, Waltham
Celgene
Location(s):
Cambridge
Charles River Laboratories
Location(s):
Shrewsburg, Wilmington, Woburn, Worcester
item[company]
Location(s):
Cambridge
item[company]
Location(s):
Cambridge
item[company]
Location(s):
Billerica, Rockland
item[company]
Location(s):
Canton
item[company]
Location(s):
Cambridge
item[company]
Location(s):
Cambridge
item[company]
Location(s):
Boston
item[company]
Location(s):
Worcester
item[company]
Location(s):
Cambridge
item[company]
Location(s):
Cambridge
item[company]
Location(s):
Boston, Marlborough, Norwood
item[company]
Location(s):
Andover, Cambridge
item[company]
Location(s):
Beverly
item[company]
Location(s):
Waltham, Mansfield
item[company]
Location(s):
Allston, Cambridge, Framingham, Northborough, Waltham
item[company]
Location(s):
Andover, Cambridge
item[company]
Location(s):
Cambridge

Massachusetts's top areas of global health R&D by USG funding

38.7%
HIV/AIDS
6.5%
Malaria
25.8%
Tuberculosis
12.3%
Diarrheal diseases
1.8%
Bacteria pneumonia & meningitis
10.1%
Neglected tropical diseases
Dengue
Helminths
Kinetoplastids
Leprosy
Trachoma
4.7%
Other
Ebola/viral hemorrhagic fevers
Hepatitis C
Non-allocable
Salmonella infections

Global health R&D at work in Massachusetts

Researchers from Harvard Medical School, Partners In Health, and Boston Children’s Hospital have shown that a new commercially developed rapid test for Ebola, performed at the point of care, was as effective as a conventional laboratory-based method. The successful field trial is a potential gamechanger. A test that can accurately diagnose Ebola within minutes provides clinicians with crucial information for treating patients and containing outbreaks.

Footnotes